Position history for BlackRock, Inc.'s holdings in DAY ONE BIOPHARMACEUTICALS I
BlackRock, Inc. holds 7M shares of DAWN (DAY ONE BIOPHARMACEUTICALS I), worth $151M as of 2026-Q1. The position was decreased (-20.3% shares). DAWN represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$151M
Current Shares
7M
Total Value Change
+$73M
Total Shares Change
+888,650
Other major holders of DAWN: FMR LLC, RA CAPITAL MANAGEMENT, L.P.
Decreased |
| 7M |
-20.3% |
| $151M |
| 0.0% |
| $10.03 |
0 |
| 2025-Q4 | Decreased | 8.8M | -1.8% | $82.4M | 0.0% | $9.18 | 0 |
| 2025-Q3 | Decreased | 9M | -8.4% | $63.5M | 0.0% | $6.99 | 0 |
| 2025-Q2 | Increased | 9.8M | +45.5% | $63.9M | 0.0% | $6.47 | 40 |
| 2025-Q1 | Increased | 6.8M | +9.8% | $53.6M | 0.0% | $8.07 | 32 |
| 2024-Q4 | New | 6.2M | - | $78M | 0.0% | $12.58 | 41 |